AMGN logo

Amgen (AMGN)

Profile

Full Name

Amgen Inc.

Ticker Symbol

AMGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

June 17, 1983

Indexes

S&P 500,NASDAQ 100,Dow Jones

Website

http://www.amgen.com

Employees

28000

Key Details

Price

$289.33(-0.10%)

Market cap

$155.57B(Mega cap)

Last Dividend

$2.38

TTM Dividend yield

3.20%

Annual revenue

$33.42B(+18.57% YoY)

Annual EPS

$7.56(-39.47% YoY)

PE ratio

26.40

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $289.33
    AMGN price is $289.33

    30-Day Relative Volume

    2.36
    AMGN 30-day relative volume is 2.36

    Price Performance

    Price Most recent change

    -0.1%
    AMGN price was down -0.1% on Jun 20, 2025

    Price YTD change

    +11.01%
    AMGN price is up +11.01% since January 1st

    Price 1-year change

    -6.63%
    AMGN price is down -6.63% year-on-year

    Price 3-year change

    +23.27%
    AMGN price is up +23.27% over the past 3 years

    Price Range

    Price All-time high

    $346.85
    AMGN price is currently -16.58% below its historical high of $346.85

    Price 3-year low

    $211.71
    AMGN price is currently +36.66% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $155.57B
    AMGN market capitalization is $155.57 billion

    Market cap 3-year change

    +24.08%
    AMGN market capitalization is up +24.08% over the past 3 years

    Market cap All-time high

    $181.28B
    AMGN market capitalization is currently -14.18% below its historical high of $181.28 billion

    Market cap sector rank

    99.18%
    AMGN market capitalization is higher than 99.18% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.24%
    AMGN shares outstanding is up +0.24% year-on-year

    Shares Outstanding 3-Year Change

    +0.66%
    AMGN shares outstanding is up +0.66% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.46
    AMGN beta is 0.46

    200-day SMA

    $295.88
    AMGN price is currently -2.21% below its 200-day simple moving average

    50-day SMA

    $282.24
    AMGN price is currently +2.51% above its 50-day simple moving average

    RSI

    53.27
    AMGN 14-day relative strength index is 53.27

    Volume

    2.36
    AMGN 30-day relative volume is 2.36

    ATR

    $5.95
    AMGN average true range is $5.95

    10-day Historical Volatility

    17.12%
    AMGN 10-day historical volatility is 17.12%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $2.38
    AMGN last dividend was $2.38 per share, with an ex-dividend date of May 16, 2025

    Next Dividend

    -
    AMGN next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $9.00
    AMGN annual dividend per share is $9.00

    Dividend per share Sector Rank

    97.65%
    AMGN annual dividend per share is higher than 97.65% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +5.63%
    AMGN annual dividend per share is up +5.63% year-on-year

    Dividend per share 3-Year Change

    +27.84%
    AMGN annual dividend per share is up +27.84% over the past 3 years

    Dividend yield

    Dividend yield

    3.11%
    AMGN annual dividend yield is 3.11%

    Dividend yield Sector Rank

    65.48%
    AMGN annual dividend yield is higher than 65.48% of companies in Healthcare sector

    Other

    Payout ratio

    118.14%
    AMGN annual payout ratio is 118.14%

    Dividends paid

    $4.83B
    AMGN annual dividends paid is $4.83 billion

    Free cash flow

    $10.39B
    AMGN annual free cash flow is $10.39 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $33.42B
    AMGN annual revenue is $33.42 billion

    Revenue Analysts estimate

    $35.27B
    AMGN annual revenue is currently -5.22% lower than the consensus analysts' forecast

    Revenue 1-year change

    +18.57%
    AMGN annual revenue is up +18.57% year-on-year

    Revenue Sector rank

    97.06%
    AMGN annual revenue is higher than 97.06% of companies in Healthcare sector

    EPS

    EPS

    $7.56
    AMGN annual earnings per share is $7.56

    EPS Analysts estimate

    $20.84
    AMGN annual earnings per share is currently -63.72% lower than the consensus analysts' forecast

    EPS 1-year change

    -39.47%
    AMGN annual earnings per share is down -39.47% year-on-year

    EPS Sector rank

    97.29%
    AMGN annual earnings per share is higher than 97.29% of companies in Healthcare sector

    Profit

    Gross profit

    $20.57B
    AMGN annual gross profit is $20.57 billion

    Gross margin

    61.53%
    AMGN annual gross profit margin is 61.53%

    Operating profit

    $7.26B
    AMGN annual operating income is $7.26 billion

    Operating margin

    21.71%
    AMGN annual operating profit margin is 21.71%

    Net income

    $4.09B
    AMGN annual net profit is $4.09 billion

    Net margin

    12.24%
    AMGN annual net profit margin is 12.24%

    Expenses

    Total expenses

    $26.17B
    AMGN annual total expenses is $26.17 billion

    Operating expenses

    $13.31B
    AMGN annual total operating expenses is $13.31 billion

    Cost of goods sold

    $12.86B
    AMGN annual cost of goods sold is $12.86 billion

    Selling, general & administrative expenses

    $7.10B
    AMGN annual SGA is $7.10 billion

    Depreciation and amortization

    $5.59B
    AMGN annual depreciation & amortization is $5.59 billion

    Interest expense

    $3.15B
    AMGN annual interest expense is $3.15 billion

    Income tax

    $519.00M
    AMGN annual income tax is $519.00 million

    EBIT & EBITDA

    EBIT

    $7.76B
    AMGN annual earnings before interest & taxes is $7.76 billion

    EBITDA

    $7.76B
    AMGN annual EBITDA is $7.76 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $91.84B
    AMGN annual total assets is $91.84 billion

    Non current assets

    $62.81B
    AMGN annual long term assets is $62.81 billion

    Current assets

    $29.03B
    AMGN annual total current assets is $29.03 billion

    Cash and cash equivalents

    $11.97B
    AMGN annual cash & cash equivalents is $11.97 billion

    Accounts receivable

    $6.78B
    AMGN annual accounts receivable is $6.78 billion

    Inventory

    $7.00B
    AMGN annual inventory is $7.00 billion

    Liabilities

    Total liabilities

    $85.96B
    AMGN annual total liabilities is $85.96 billion

    Long term liabilities

    $62.86B
    AMGN annual total long term liabilities is $62.86 billion

    Current liabilities

    $23.10B
    AMGN annual total current liabilities is $23.10 billion

    Accounts payable

    $1.91B
    AMGN annual accounts payable is $1.91 billion

    Debt

    Total debt

    $60.10B
    AMGN annual total debt is $60.10 billion

    Total debt 1-year change

    -6.99%
    AMGN annual total debt is down -6.99% year-on-year

    Long term debt

    $56.55B
    AMGN annual long term debt is $56.55 billion

    Short term debt

    $3.55B
    AMGN annual short term debt is $3.55 billion

    Equity & Capital

    Shareholders equity

    $5.88B
    AMGN annual stockholders equity is $5.88 billion

    Book value

    $5.88B
    AMGN annual book value is $5.88 billion

    Retained earnings

    -$27.59B
    AMGN annual retained earnings is -$27.59 billion

    Working capital

    $5.93B
    AMGN annual working capital is $5.93 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $11.49B
    AMGN annual cash flow from operations is $11.49 billion

    Cash from operations 1-year change

    +35.64%
    AMGN annual cash flow from operations is up +35.64% year-on-year

    Cash from investing

    -$1.05B
    AMGN annual cash flow from investing activities is -$1.05 billion

    Cash from investing 1-year change

    +96.01%
    AMGN annual cash flow from investing activities is up +96.01% year-on-year

    Cash from financing

    -$9.41B
    AMGN annual cash flow from financing activities is -$9.41 billion

    Cash from financing 1-year change

    -144.73%
    AMGN annual cash flow from financing activities is down -144.73% year-on-year

    CAPEX

    CAPEX

    $1.10B
    AMGN annual capital expenditures is $1.10 billion

    CAPEX 1-year change

    -1.44%
    AMGN annual capital expenditures is down -1.44% year-on-year

    Free Cash Flow

    Free cash flow

    $10.39B
    AMGN annual free cash flow is $10.39 billion

    Free cash flow 1-year change

    +41.24%
    AMGN annual free cash flow is up +41.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    61.53%
    AMGN annual gross profit margin is 61.53%

    Operating margin

    21.71%
    AMGN annual operating profit margin is 21.71%

    Net margin

    12.24%
    AMGN annual net profit margin is 12.24%

    ROA & ROE

    ROA

    4.33%
    AMGN annual return on assets is 4.33%

    ROE

    67.55%
    AMGN annual return on equity is 67.55%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    26.40
    AMGN price to earnings ratio is 26.40

    PE ratio Sector rank

    54.67%
    AMGN price to earnings ratio is higher than 54.67% of companies in Healthcare sector

    PB Ratio

    PB ratio

    25.06
    AMGN price to book ratio is 25.06

    PB ratio Sector rank

    96.64%
    AMGN price to book ratio is higher than 96.64% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.56
    AMGN price to sales ratio is 4.56

    PS ratio Sector rank

    61.74%
    AMGN price to sales ratio is higher than 61.74% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $204.15B
    AMGN enterprise value is $204.15 billion

    Enterprise value Sector rank

    99.26%
    AMGN enterprise value is higher than 99.26% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    13.36
    AMGN EV/EBITDA is 13.36

    EV/EBITDA Sector rank

    87.04%
    AMGN EV/EBITDA is higher than 87.04% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.26
    AMGN annual current ratio is 1.26

    Quick ratio

    0.95
    AMGN annual quick ratio is 0.95

    Leverage

    Debt to equity

    10.23
    AMGN annual debt to equity ratio is 10.23

    Interest coverage ratio

    2.46
    AMGN annual interest coverage ratio is 2.46

    Risk & Stability

    Piotroski F-Score

    7
    AMGN piotroski f-score is 7

    Altman Z-Score

    1.39
    AMGN altman z-score is 1.39

    Analyst ratings

    Recent major analysts updates

    May 16, 25 Piper Sandler
    Overweight
    May 7, 25 Mizuho
    Neutral
    May 2, 25 UBS
    Neutral
    May 2, 25 RBC Capital
    Outperform
    Apr 22, 25 Cantor Fitzgerald
    Overweight
    Apr 14, 25 UBS
    Neutral
    Apr 9, 25 Morgan Stanley
    Equal-Weight
    Mar 5, 25 B of A Securities
    Underperform
    Feb 10, 25 Piper Sandler
    Overweight
    Feb 6, 25 B of A Securities
    Underperform

    Institutional Ownership

    Screeners with AMGN included

    Highest dividend in sector
    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    NASDAQ 100 companies
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    • What is the ticker symbol for Amgen?
    • Does Amgen pay dividends?
    • What sector is Amgen in?
    • What industry is Amgen in?
    • What country is Amgen based in?
    • When did Amgen go public?
    • Is Amgen in the S&P 500?
    • Is Amgen in the NASDAQ 100?
    • Is Amgen in the Dow Jones?
    • When was Amgen's last earnings report?
    • When does Amgen report earnings?
    • Should I buy Amgen stock now?

    What is the ticker symbol for Amgen?

    The ticker symbol for Amgen is NASDAQ:AMGN

    Does Amgen pay dividends?

    Yes, Amgen pays dividends. The last payment was $2.38, with an ex-dividend date on May 16, 2025

    What sector is Amgen in?

    Amgen is in the Healthcare sector

    What industry is Amgen in?

    Amgen is in the Drug Manufacturers - General industry

    What country is Amgen based in?

    Amgen is headquartered in United States

    When did Amgen go public?

    Amgen's initial public offering (IPO) was on June 17, 1983

    Is Amgen in the S&P 500?

    Yes, Amgen is included in the S&P 500 index

    Is Amgen in the NASDAQ 100?

    Yes, Amgen is included in the NASDAQ 100 index

    Is Amgen in the Dow Jones?

    Yes, Amgen is included in the Dow Jones index

    When was Amgen's last earnings report?

    Amgen's most recent earnings report was on May 1, 2025

    When does Amgen report earnings?

    The next expected earnings date for Amgen is Aug 6, 2025

    Should I buy Amgen stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page